antibody-drug conjugates

ADCs, market analysis, analyse marché, anticorps conjugués, anticorps armés, monoclonal antibody conjugated, immunoconjugués

This month’s MabDesign market analysis gives you an overview of the antibody-drug conjugates market and projects in development.

Monoclonal antibodies: the stars of therapeutic proteins

mAbs, anticorps monoclonal monoclonaux

Hybridoma technology for the production of monoclonal antibodies (mAbs), awarded the Nobel Prize for Medicine in 1984, revolutionized serotherapy, which previously used patient serum containing mixtures of antibodies. More targeted and therefore more effective, mAbs offer innovative perspectives in the treatment of various diseases, and have become an essential therapeutic strategy in our pharmaceutical arsenal.